Approval and regulation of medications and devices in children

Industry ties and conflicts of interest in drug reviews and meta-analyses

Transparency and reporting of clinical trials in pediatric populations

Opioid use among children treated in ambulatory settings

Impact of Prescription Drug Monitoring Programs on pediatric opioid poisonings and overdoses

Discontinuation and non-publicaiton of clinical trials for rare diseases in children

Translation of published research findings into clinical practice

Completion and publication of FDA-mandated pediatric trials